Recombinant Human CYGB Protein，His

Cytochrome b561 (CYGB) is a heme-containing protein that plays a crucial role in electron transport and redox reactions within the cell, particularly in the context of mitochondrial and plasma membrane functions. Research into CYGB has gained traction due to its potential implications in various physiological processes, including oxidative stress response, cellular signaling, and oxygen regulation. Notably, CYGB's expression is observed in diverse tissues, suggesting its involvement in critical metabolic pathways. Studies have indicated that CYGB may participate in metabolic adaptation under hypoxic conditions and could be linked to various diseases, such as cancer and cardiovascular disorders. The recombinant expression of CYGB in model systems allows for the detailed study of its structural properties, functional mechanisms, and interactions with other cellular components. This research is not only fundamental for understanding CYGB's biological roles but also holds promise for therapeutic applications, such as gene therapy and the development of novel antioxidant strategies. As investigations continue to unravel the intricacies of CYGB, its role as a potential biomarker and therapeutic target in disease contexts is increasingly recognized, emphasizing the need for enhanced recombinant protein production techniques to facilitate further exploration.